•Potent
anti-RIPK2 activity (IC50
134nM), high specificity for RIPK2
•Good
in vitro and in vivo efficacy (including multiple sclerosis)
•Delay
in NF-kB transcription factor activation
•Bioavailability
in mice
•No
pathology or changes to white blood cells observed at the maximum tolerated